Online Education Opportunities

November 1, 2021
  • Rise Up As A Resilient Healthcare Worker - Masterclass Series

    November 1, 2021

    FREE! Complete at your own pace, available online anytime! 

    Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

    Take advantage of this unique masterclass series designed exclusively for healthcare leaders

    What you'll get:

    • Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

    •  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

    •  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

    Each masterclass comes with a workbook to guide your learning experience. 

    See more details

November 3, 2021
  • Children's Hospital Colorado: 23rd Annual Pediatric Infectious Diseases Update, Wednesday, November 3, 2021 -

    November 3, 2021

    Children's Hospital Colorado 
    invites you to attend our Annual Pediatric Infectious Diseases Update


    Registration is Open!

    Click on the link below to download the brochure and to register: 

    Register here

    If you have any questions please contact Kris Beam at:
    720-777-6671 or email kris.beam@childrenscolorado.org.

    See more details

  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    November 3, 2021

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

November 5, 2021
  • AMA Edu Hub presents: Opioid CME Portal

    November 5, 2021

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

November 8, 2021
  • WAPA 2021 Fall Conference

    November 8, 2021 - November 10, 2021  

    Register here: https://wapa.mypanetwork.com/physician-assistant-events/619-wapa-s-2021-virtual-fall-conference#!registration

    See more details

November 9, 2021
  • WAPA 2021 Fall Conference

    November 8, 2021 - November 10, 2021  

    Register here: https://wapa.mypanetwork.com/physician-assistant-events/619-wapa-s-2021-virtual-fall-conference#!registration

    See more details

  • MSRGN Presents: Genetics Summits 2021

    November 9, 2021 - November 10, 2021  

    A virtual summit to educate, engage, and connect families, providers, and public health professionals around contemporary topics in genetics.

    November 9, 2021—November 10, 2021

    8:30am - 1:30pm PT // 9:30am - 2:30pm MT

    10:30am - 3:30pm CT // 11:30am - 4:30pm ET

    Click for more information or to register: https://web.cvent.com/event/f41351a8-9a5e-404f-adcf-6950a60fe529/summary

    See more details

November 10, 2021
  • WAPA 2021 Fall Conference

    November 8, 2021 - November 10, 2021  

    Register here: https://wapa.mypanetwork.com/physician-assistant-events/619-wapa-s-2021-virtual-fall-conference#!registration

    See more details

  • MSRGN Presents: Genetics Summits 2021

    November 9, 2021 - November 10, 2021  

    A virtual summit to educate, engage, and connect families, providers, and public health professionals around contemporary topics in genetics.

    November 9, 2021—November 10, 2021

    8:30am - 1:30pm PT // 9:30am - 2:30pm MT

    10:30am - 3:30pm CT // 11:30am - 4:30pm ET

    Click for more information or to register: https://web.cvent.com/event/f41351a8-9a5e-404f-adcf-6950a60fe529/summary

    See more details

November 12, 2021
  • Gender Health Education Summit

    November 12, 2021 - November 14, 2021  

    Sex and Gender Health Education Summit
    November 12-14, 2021
    www.sghesummit.com

    The Summit is a follow-up to prior Summits which have brought together healthcare educators from over 250 institutions and associations to advance sex and gender specific health education. 

    We invite you or your curricular leader to attend (free) with the code: guest. 

    See more details

November 13, 2021
  • Gender Health Education Summit

    November 12, 2021 - November 14, 2021  

    Sex and Gender Health Education Summit
    November 12-14, 2021
    www.sghesummit.com

    The Summit is a follow-up to prior Summits which have brought together healthcare educators from over 250 institutions and associations to advance sex and gender specific health education. 

    We invite you or your curricular leader to attend (free) with the code: guest. 

    See more details

November 14, 2021
  • Gender Health Education Summit

    November 12, 2021 - November 14, 2021  

    Sex and Gender Health Education Summit
    November 12-14, 2021
    www.sghesummit.com

    The Summit is a follow-up to prior Summits which have brought together healthcare educators from over 250 institutions and associations to advance sex and gender specific health education. 

    We invite you or your curricular leader to attend (free) with the code: guest. 

    See more details

November 19, 2021
  • AMA Edu Hub presents: Opioid CME Portal

    November 19, 2021

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

November 22, 2021
  • Rockpointe Presents:

    November 22, 2021

    The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

    Register Here:
    https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

    See more details

November 24, 2021
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    November 24, 2021

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

December 1, 2021
  • Rise Up As A Resilient Healthcare Worker - Masterclass Series

    December 1, 2021

    FREE! Complete at your own pace, available online anytime! 

    Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

    Take advantage of this unique masterclass series designed exclusively for healthcare leaders

    What you'll get:

    • Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

    •  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

    •  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

    Each masterclass comes with a workbook to guide your learning experience. 

    See more details

December 3, 2021
  • AMA Edu Hub presents: Opioid CME Portal

    December 3, 2021

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

December 4, 2021
  • Rowan University CME Series

    December 4, 2021

    5-Block CME Series
    September 11, 2021  -  Cardiology

    September 18, 2021  -  Endocrine / Weight Management

    October 9, 2021  -  Psychiatry / Psychology

    October 23, 2021  -  Internal Medicine

    December 4, 2021  -  Musculoskeletel / Joint Conditions

    25.5 Category 1-A CME Credits / 25.5 AMA PRA Category 1 CME Credits

     

    To register or for more information, please visit:  www.rowan.edu/som/cme

    Questions, please contact: Tara Shontz, CME Coordinator at 856-566-6358 / 856-272-2617 or by email at cme@rowan.edu.

    See more details

December 15, 2021
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    December 15, 2021

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

December 17, 2021
  • AMA Edu Hub presents: Opioid CME Portal

    December 17, 2021

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

December 27, 2021
  • Rockpointe Presents:

    December 27, 2021

    The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

    Register Here:
    https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

    See more details

December 31, 2021
  • AMA Edu Hub presents: Opioid CME Portal

    December 31, 2021

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

January 1, 2022
  • Rise Up As A Resilient Healthcare Worker - Masterclass Series

    January 1, 2022

    FREE! Complete at your own pace, available online anytime! 

    Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

    Take advantage of this unique masterclass series designed exclusively for healthcare leaders

    What you'll get:

    • Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

    •  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

    •  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

    Each masterclass comes with a workbook to guide your learning experience. 

    See more details

January 5, 2022
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    January 5, 2022

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

January 14, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    January 14, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

January 24, 2022
  • Rockpointe Presents:

    January 24, 2022

    The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

    Register Here:
    https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

    See more details

January 26, 2022
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    January 26, 2022

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

January 28, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    January 28, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

February 1, 2022
  • Rise Up As A Resilient Healthcare Worker - Masterclass Series

    February 1, 2022

    FREE! Complete at your own pace, available online anytime! 

    Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

    Take advantage of this unique masterclass series designed exclusively for healthcare leaders

    What you'll get:

    • Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

    •  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

    •  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

    Each masterclass comes with a workbook to guide your learning experience. 

    See more details

February 11, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    February 11, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

February 16, 2022
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    February 16, 2022

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

February 25, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    February 25, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

February 28, 2022
  • Rockpointe Presents:

    February 28, 2022

    The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

    Register Here:
    https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

    See more details

March 1, 2022
  • Rise Up As A Resilient Healthcare Worker - Masterclass Series

    March 1, 2022

    FREE! Complete at your own pace, available online anytime! 

    Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

    Take advantage of this unique masterclass series designed exclusively for healthcare leaders

    What you'll get:

    • Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

    •  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

    •  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

    Each masterclass comes with a workbook to guide your learning experience. 

    See more details

March 9, 2022
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    March 9, 2022

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

March 11, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    March 11, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

March 25, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    March 25, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

March 28, 2022
  • Rockpointe Presents:

    March 28, 2022

    The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

    Register Here:
    https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

    See more details

March 30, 2022
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    March 30, 2022

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

April 1, 2022
  • Rise Up As A Resilient Healthcare Worker - Masterclass Series

    April 1, 2022

    FREE! Complete at your own pace, available online anytime! 

    Register here: https://www.trainingmissinglogic.com/offers/oyMYNa6F/checkout

    Take advantage of this unique masterclass series designed exclusively for healthcare leaders

    What you'll get:

    • Masterclass 1:  Finding Stability in a World of Crisis and Chaos 

    •  Masterclass 2:  Becoming a Resilient Leader During Unprecedented Times 

    •  Masterclass 3:  Living a Balanced Life Through the Hard Times and Beyond

    Each masterclass comes with a workbook to guide your learning experience. 

    See more details

April 8, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    April 8, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

April 20, 2022
  • Rockpointe presents: Pustular Psoriasis: Recognizing and Treating A Rare But Serious Disease

    April 20, 2022

    This activity can be taken anytime.

    Register here: https://www.rockpointe.com/courses/pustular-psoriasis-recognizing-and-treating-a-rare-but-serious-disease-2/

    Pustular psoriasis is a clinically heterogenous group of rare psoriasis subtypes characterized by aseptic, neutrophil-rich pustules. The three most common types are generalized pustular psoriasis, palmoplantar pustular psoriasis, and acrodermatitis continua of Hallopeau. The diagnosis of pustular psoriasis relies mainly on clinical features and is challenging. Recent guidelines on diagnosis, classification, and assessment of severity have been published by ERASPEN and by the Japanese Dermatological Association.

    See more details

April 22, 2022
  • AMA Edu Hub presents: Opioid CME Portal

    April 22, 2022

    The AMA has a portal of opioid-related CME courses.

    Click here to access the portal:
    https://edhub.ama-assn.org/pages/opioid-cme-course

    See more details

April 25, 2022
  • Rockpointe Presents:

    April 25, 2022

    The incidence of nonmelanoma skin cancers (NMSC), including cutaneous squamous cell carcinomas (CSCC) and basal cell carcinomas (BCC), is increasing globally. Although these cancers are treatable with surgery or radiotherapy, locally advanced or metastatic forms of these carcinomas are life-threatening, difficult to treat, are not amenable to those standard options, and historically, have had few treatment options. Greater knowledge of the role of the immune system in the development of cancer, and of the role of programmed death-1 (PD-1) in evading immune clearance, has led to the study of PD-1 and PD-L1 inhibitors in the management of advanced and metastatic NMSCs. This research has led to the approval of a checkpoint inhibitor as the first treatment specifically for advanced CSCC and the continued development of checkpoint inhibitors for treating advanced BCC. Oncologists need to be aware of what constitutes a thorough diagnostic evaluation and accurate staging of patients to develop more effective individualized, evidence-based management plans. In addition, oncologists need to understand current evidence regarding the use of immunotherapies such as checkpoint inhibitors.

    Register Here:
    https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/

    See more details